Open: 0.0 Close: 0.0 Change: 0.0

Today's Summary

galecto Incs short interest as a percentage of float has risen 7.93% since its last report. the company has more short interest than most of its peers. benzinga is a clinical-stage biotechnology company advancing a pipeline of antibody therapeutics.Galecto intends to use its website as a means of disclosing material non-public information. such forward-looking statements include statements about GB3226. a new drug application could be submitted to the FDA. the company is a clinical-stage biopharmaceutical company.